NCT03391401View on ClinicalTrials.gov

Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery

CompletedOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

January 31, 2021

Study Completion Date

July 31, 2021

Conditions
Obesity, MorbidBariatric Surgery CandidateNAFLDMicrobiome
Interventions
PROCEDURE

Bariatric surgery

Any bariatric operation that is considered as a standard procedure in bariatric surgery (i.e. sleeve gastrectomy, roux-en-y gastric bypass, mini-gastric / one anastomosis gastric bypass, redo and revisional bariatric surgery).

Trial Locations (2)

50825

St. Franziskus-Hospital, Cologne

53127

University of Bonn, Bonn

All Listed Sponsors
collaborator

University of Bonn

OTHER

lead

St. Franziskus Hospital

OTHER

NCT03391401 - Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery | Biotech Hunter | Biotech Hunter